Literature DB >> 34796292

Differences in 5-Aminolevulinic Acid-Induced Hemodynamic Changes between Patients Undergoing Neurosurgery and Urological Surgery.

Tohru Shiratori1, Kunihisa Hotta2, Masaaki Satoh2, Atsushi Sato3, Takayuki Kamigaito4, Chiaki Kiuchi1, Ryusuke Tanaka1.   

Abstract

INTRODUCTION: Oral 5-aminolevulinic acid (5-ALA) is often used for photodynamic diagnosis-assisted glioma or bladder tumor surgery. 5-ALA affects blood pressure (BP). In fact, hypotension is a well-known adverse effect of 5-ALA in urology. However, information regarding 5-ALA-induced hemodynamic changes in neurosurgery remains limited. Furthermore, the duration of hypotension and how 5-ALA affects the heart rate (HR) are yet to be determined. Thus, in this study, we aimed to elucidate 5-ALA-induced perioperative hemodynamic changes in neurosurgery and urological surgery by examining real-world data.
METHODS: Consecutive patients who underwent neurosurgery (neurosurgery patients; 5-ALA-pretreated vs. non-pretreated [17 vs. 16], from January 2014 to March 2021) and urological surgery (urological surgery patients; 5-ALA-pretreated vs. non-pretreated [26 vs. 101], from August 2018 to September 2020) were enrolled. Differences in hemodynamics were evaluated using the linear mixed model. BP and HR in 5-ALA-pretreated patients were compared with those in non-pretreated patients. Differences in 5-ALA-induced preoperative BP changes were compared between the neurosurgery patients and urological surgery patients.
RESULTS: 5-ALA scarcely affected the hemodynamics in neurosurgery patients, whereas 5-ALA-induced hemodynamic changes were clearly observed in urological surgery patients. Hemodynamic parameters were found to be not significantly different between 5-ALA-pretreated and non-pretreated neurosurgery patients. The preoperative, intraoperative, and postoperative BP in 5-ALA-pretreated urological surgery patients were significantly lower than those in the non-pretreated patients. Preoperatively, two 5-ALA-pretreated urological surgery patients had severe postural hypotension (systolic BP <50 mmHg), and one of them did not continue with the surgery because of prolonged severe hypotension. The BP in 5-ALA-pretreated urological surgery patients tended to be persistently lower for 9 h after 5-ALA pretreatment. The preoperative and postoperative HR values were higher in 5-ALA-pretreated urological surgery patients. Cumulative incidences of BP reduction and HR elevation were significantly higher in 5-ALA-pretreated urological surgery patients. The preoperative BP reduction in 5-ALA-pretreated urological surgery patients was significantly larger than that in neurosurgery patients.
CONCLUSIONS: 5-ALA-induced hemodynamics may differ between neurosurgery patients and urological surgery patients. 5-ALA may affect BP for at least 9 h.
Copyright © Japan Medical Association.

Entities:  

Keywords:  Aminolevulinic acid; blood pressure; glioma; heart rate; hemodynamics; hypotension; photodynamic therapy; urinary bladder neoplasms

Year:  2021        PMID: 34796292      PMCID: PMC8580708          DOI: 10.31662/jmaj.2021-0092

Source DB:  PubMed          Journal:  JMA J        ISSN: 2433-328X


  23 in total

1.  Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence.

Authors:  W Stummer; S Stocker; S Wagner; H Stepp; C Fritsch; C Goetz; A E Goetz; R Kiefmann; H J Reulen
Journal:  Neurosurgery       Date:  1998-03       Impact factor: 4.654

2.  Severe and Prolonged Hypotension After Oral 5-Aminolevulinic Acid Administration in a Patient With End-Stage Renal Disease Undergoing Transurethral Resection of a Bladder Tumor: A Case Report.

Authors:  Tatsuya Kida; Teisei Kobashi; Yutaka Usuda; Kazuki Kobayashi; Masakazu Sumitomo
Journal:  A A Pract       Date:  2020-01-01

3.  Impact of age, body mass index, and renal function for severe hypotension caused by oral 5-aminolevulinic acid administration in patients undergoing transurethral resection of bladder tumor.

Authors:  Jimpei Miyakawa; Taketo Kawai; Katsuhiro Makino; Yoshiyuki Akiyama; Yuta Yamada; Masaki Nakamura; Yusuke Sato; Daisuke Yamada; Motofumi Suzuki; Haruki Kume
Journal:  Photodiagnosis Photodyn Ther       Date:  2021-01-08       Impact factor: 3.631

4.  Evaluation of bladder tumor volume and CT number during radiotherapy: a comment on the paper by Swank-Bordewijk and van Kleffens.

Authors:  S M Bentzen; A Jakobsen; J Jørgensen
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-06       Impact factor: 7.038

5.  Clinical experience with 5-aminolevulinic acid and photodynamic therapy for refractory superficial bladder cancer.

Authors:  R Waidelich; H Stepp; R Baumgartner; E Weninger; A Hofstetter; M Kriegmair
Journal:  J Urol       Date:  2001-06       Impact factor: 7.450

6.  Risk factors for developing oral 5-aminolevulinic acid-induced side effects in patients undergoing fluorescence guided resection.

Authors:  Ivan Wong Hin Chung; Sam Eljamel
Journal:  Photodiagnosis Photodyn Ther       Date:  2013-04-29       Impact factor: 3.631

7.  Clinical uses of 5-aminolaevulinic acid in photodynamic treatment and photodetection of cancer: A review.

Authors:  Adriana Casas
Journal:  Cancer Lett       Date:  2020-06-10       Impact factor: 8.679

8.  Oral 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A multicenter phase III study.

Authors:  Yasushi Nakai; Keiji Inoue; Toyonori Tsuzuki; Tsutomu Shimamoto; Taro Shuin; Kazuhiro Nagao; Hideyasu Matsuyama; Masafumi Oyama; Hiroshi Furuse; Seiichiro Ozono; Makito Miyake; Kiyohide Fujimoto
Journal:  Int J Urol       Date:  2018-07-12       Impact factor: 3.369

9.  5-Aminolevulinic acid-induced severe hypotension during transurethral resection of a bladder tumor: a case report.

Authors:  Tomoaki Yatabe; Shigematsu-Locatelli Marie; Hideo Fukuhara; Takeshi Karashima; Keiji Inoue; Masataka Yokoyama
Journal:  JA Clin Rep       Date:  2019-09-04

10.  Identification of risk factors for post-induction hypotension in patients receiving 5-aminolevulinic acid: a single-center retrospective study.

Authors:  Tomoaki Yatabe; Takashi Karashima; Motohiko Kume; Yu Kawanishi; Hideo Fukuhara; Tetsuya Ueba; Keiji Inoue; Yoshiyasu Okuhara; Masataka Yokoyama
Journal:  JA Clin Rep       Date:  2020-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.